Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04065399
Title	A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101)
Acronym	AUGMENT-101
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Syndax Pharmaceuticals
Indications	acute myeloid leukemia acute lymphoblastic leukemia
Therapies	Revumenib
Age Groups:	child \| senior \| adult
Covered Countries	USA \| NLD \| LTU \| ITA \| ISR \| FRA \| ESP \| DEU \| CAN \| AUS